The Lancet Gastroenterology & Hepatology in conversation with

Colorectal cancer risk in patients with Crohn’s disease

The Lancet

Ola Olén discusses the assesment of colorectal cancer risk in patients with Crohn's disease.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv